Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
98.90%
Operating Margin
7.76%
Net Margin
43.91%
Efficiency Metrics
Revenue per Expense Ratio
1.00
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
0.00%
Income Tax Rate
-459,400,000.0%
EPS
2.9200000000
Balance Sheet Analysis
Current Ratio
0.13
Cash Ratio
-0.02
Working Capital
$-29.50B
Debt to Equity
0.89
Debt to Assets
9.36%
Equity Ratio
10.56%
Cash Flow Analysis
Operating Cash Flow Ratio
48.34%
Free Cash Flow Ratio
40.39%
CapEx to Revenue
7.96%
Dividends Paid
$181.28M
Stock Buybacks
$2.41M
Total Shareholder Returns
$183.69M
Cash Position Change
112.06%
Key Takeaways (2023 FY)
Revenue declined by 33.037490477598%, indicating potential market challenges
Maintained positive net income growth despite revenue changes
Increased dividend payments by 6.99%
Detailed Growth Metrics
Core Performance
Revenue
-33.04%
Net Income
17.07%
EPS
18.22%
Operating Income
-88.14%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-8.74%
Operating Cash Flow
-39.78%
Free Cash Flow
-44.77%
Balance Sheet Health
Assets
0.58%
Debt
10.54%
Book Value per Share
20.46%
Inventory
0.00%
Shareholder Returns
Dividends per Share
6.99%
Shares Outstanding
-0.49%
Long Term Trends
3Y Revenue/Share
-32.19%
5Y Revenue/Share
-21.92%
3Y Dividend/Share
18.99%
5Y Dividend/Share
59.64%